U.S., EU investigate link between Raptiva, brain disease

02/19/2009 | Bloomberg · Los Angeles Times (tiered subscription model)

The FDA and the European Medicines Agency are investigating a possible link between Genentech's psoriasis drug Raptiva and progressive multifocal leukoencephalopathy, a deadly brain infection. The agencies received three reports of deaths and one possible case of the disease. Genentech and its European partner Merck KGaA said they are working with the regulators to address the issue.

View Full Article in:

Bloomberg · Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD